# EDGAR Filing Document

**Accession Number:** 0001645460
**File Stem:** 0000000000-26-002905
**Filing Date:** 2026-3
**Character Count:** 2236
**Document Hash:** 1a9f7805a453c5d34027b874a7ed900a
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000000000-26-002905.hdr.sgml**: 20260505

**ACCESSION NUMBER**: 0000000000-26-002905

**CONFORMED SUBMISSION TYPE**: UPLOAD

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20260323

**FILED FOR**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Cue Biopharma, Inc.
- **CENTRAL INDEX KEY:** 0001645460
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 473324577
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** UPLOAD
- **SEC FILE NUMBER:** 333-294366

**BUSINESS ADDRESS:**
- **STREET 1:** 40 GUEST STREET
- **CITY:** BOSTON
- **STATE:** MA
- **ZIP:** 02135
- **BUSINESS PHONE:** 617-949-2680

**MAIL ADDRESS:**
- **STREET 1:** 40 GUEST STREET
- **CITY:** BOSTON
- **STATE:** MA
- **ZIP:** 02135

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Imagen Biopharma, Inc.
- **DATE OF NAME CHANGE:** 20150617
**PUBLIC REFERENCE ACCESSION NUMBER**: 0001193125-26-108656

## Text-Extract

```

                                                           March 23, 2026

Lucinda Warren
Chief Financial and Business Officer
Cue Biopharma, Inc.
40 Guest Street
Boston, Massachusetts 02135

       Re: Cue Biopharma, Inc.
           Registration Statement on Form S-3
           Filed March 16, 2026
           File No. 333-294366
Dear Lucinda Warren:

       This is to advise you that we have not reviewed and will not review your
registration
statement.

        Please refer to Rules 460 and 461 regarding requests for acceleration.
We remind you
that the company and its management are responsible for the accuracy and
adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action
by the staff.

       Please contact Tim Buchmiller at 202-551-3635 with any questions.

                                                           Sincerely,

                                                           Division of
Corporation Finance
                                                           Office of Life
Sciences
cc:    Caroline Dotolo, Esq.

```

### Attached PDF Documents

**Attachment 1:** `filename1`

_No text found in this document._